AmpliMed, Handok Pharmaceuticals Co. Ltd. deal

Handok received exclusive, Korean rights to AmpliMed's Amplimexon imexon to treat cancer. AmpliMed will receive an undisclosed upfront fee and is eligible for development and regulatory milestones. T...